Trial Profile
A randomized, multicenter, double-blind, placebo controlled, parallel study to assess the efficacy and safety of the combined administration of sertraline and lamotrigine in subjects with chronic low back pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2015
Price :
$35
*
At a glance
- Drugs Lamotrigine/sertraline (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Meditop Pharmaceutical
- 07 Feb 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 19 May 2014 New trial record